Matt Windsor
| This email address is being protected from spambots. You need JavaScript enabled to view it.Could NET-wielding neutrophils be driving respiratory distress and death in COVID-19 patients?
The immune system’s first responders are implicated in acute respiratory distress syndrome, which greatly increases mortality in patients with COVID-19. With pilot funding from UAB’s urgent COVID-19 research initiative, investigators are exploring a potentially powerful new form of treatment.
The Census deadline is Sept. 30. If you haven’t completed this 10-minute process, here are six ways that 600-second investment will benefit you.
Your questions answered from Sept. 15 student town hall
UAB leaders shared insights on the first weeks of fall semester and upcoming parking changes and answered questions on flu shots, residence halls, spring semester and more.
‘Our safety measures are working’: Data and answers from Sept. 11 employee town hall
UAB leaders discussed data and reactions from the first weeks of fall semester and answered questions on mask compliance, work restrictions, benefits changes and more.
Savings can buy peace of mind. Here’s how to get help
Depression symptoms are rising during the pandemic, but a new study shows that having a healthy savings account has a protective effect. Free financial counseling from UAB and other employee training resources offer a step-by-step guide to savings success.
Better tests, cheaper vaccines: Antibody expert turns to COVID-19
Moon Nahm, M.D., has identified the crucial antibodies for pneumococcal vaccines and helped lower prices from $100 per dose to $2. With pilot funding from UAB’s urgent COVID-19 research initiative, Nahm is adapting his proven techniques to SARS-CoV-2.
How UAB became a national leader in clinical trials
Alabamians have early access to potentially life-saving vaccines and treatments for COVID-19 through UAB. Why? The same reasons that clinical trials activity at UAB has more than doubled in the past five years. Here's how it happened.
This glow-in-the-dark Trojan horse makes cancer cells build their own self-destruct switch
A bioluminescent one-two punch targets mitochondria in cancer cells and evades the blood-brain barrier for a potential new treatment for neuroendocrine cancers, triple-negative breast cancer and brain cancers.
New studies test convalescent plasma for COVID-19 treatment — and prevention
UAB is enrolling patients as part of randomized controlled trials that experts say are necessary to prove the efficacy of the much-discussed COVID-19 treatment.
In a new trial funded through UAB’s urgent COVID-19 research program, investigators are comparing the widely available steroid methylprednisolone with dexamethasone, which lowered risk of dying by one-third in a U.K. trial this summer.
